Neuroprotection in early stages of glaucoma
Egorov E.A.

Pirogov Russian National Research Medical University, Moscow
Glaucoma is a neurodegenerative disease characterized by progressive optic neuropathy, pathological changes of visual field and loss of retinal ganglion cells. Lowering of an intraocular pressure cannot guarantee a stabilization of glaucoma progress. Neuroprotection as the milestone of glaucoma treatment is discussed in the article. Particular attention is given to efficacy of Retinalamine in patients with POAG.

Key words: glaucoma, neuroprotection, pharmacotherapy.

For citation: Egorov E.A. Neuroprotection in early stages of glaucoma. // RMJ. Clinical ophthalomology. 2015. № 2. P. 154–159.